perioperative management of glp-1 agonists How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Patients on Glucagon-Like Perioperative management of patients taking
Description
Research shows that virtual eating disorder treatment is as effective as in-person treatment, but each person and their care team should thoughtfully decide whats best for them personally
About a quarter of non-carriers reached the recommended HbA1c target after six months of treatment, compared with 11.5% of participants with the p.S539W variant and 18.5% of participants with the p.D563G variant
These risks include quality and safety issues, incorrect dosages, falsified products, and lack of regulatory oversight
Severe hypoglycemia Risk increases if used with other diabetes medications like insulin
A new synthetic dual agonist of GPR120/GPR40 induces GLP-1 secretion and improves glucose homeostasis in mice
doi:10.1002/dmrr.3070 61
